IP Library Granted Patent US 7,744,921
Granted Patent B2
US 7,744,921 · App. 11/842,130 · Granted Jun 29, 2010

Liposome loading with metal ions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,744,921
App. No.
11/842,130
Granted
Jun 29, 2010
Kind
B2
Abstract

This invention relates to encapsulation of drugs and other agents into liposomes.

Claims (27)

1. A method of loading at least one therapeutic agent into a liposome in a liposome composition, the method comprising:

i) providing a composition comprising liposomes, said liposomes lacking an ionophore, in an external solution, the liposomes containing an internal copper-ion compatible solution comprising encapsulated copper ions;

ii) adding at least one therapeutic agent to the external solution; and

iii) maintaining the agent in the external solution for sufficient time to load the agent into the liposomes, whereby said copper or cobalt ions effect said loading;

wherein the external solution and external surfaces of the liposome contain substantially no uncomplexed copper ions; and

wherein the liposomes comprise 0-20 mol % cholesterol.

2. The method of claim 1 , wherein the external solution comprises a copper chelating agent.

3. The method of claim 1 , wherein uncomplexed copper ions are removed from the external solution prior to step (ii) by chromatography or by extensive solution exchange or dialysis.

4. The method of claim 1 , wherein the internal solution and the external solution have substantially the same pH.

5. The method of claim 1 , wherein the pH of the internal solution is in the range of about 6.0 to about 8.5.

6. The method of claim 1 , wherein the liposomes comprise one or more lipids that are negatively charged at physiological pH.

7. The method of claim 6 , wherein the one or more negatively charged lipids are selected from PG and PI.

8. The method of claim 1 , wherein a second therapeutic agent is loaded by means of a transmembrane gradient established with an ionophore supplied to the liposomes after step (iii).

9. A method of loading at least one therapeutic agent into a liposome in a liposome composition, the method comprising:

i) providing a composition comprising liposomes in an external solution, the liposomes containing an internal copper-ion compatible solution comprising encapsulated copper ions;

ii) adding at least one therapeutic agent to the external solution; and

iii) maintaining the agent in the external solution for sufficient time to load the agent into the liposomes,

wherein the external solution and external surfaces of the liposome contain substantially no uncomplexed copper ions; and

wherein the liposomes comprise 0-20 mol % cholesterol; and

wherein the liposomes do not at any time during said loading comprise an ionophore, whereby said copper ions effect said loading.

10. A method of loading at least one therapeutic agent into a liposome in a liposome composition, the method comprising:

i) providing a composition comprising liposomes in an external solution, the liposomes containing an internal copper-ion compatible solution comprising encapsulated copper ions;

ii) adding at least one therapeutic agent to the external solution; and

iii) maintaining the agent in the external solution for sufficient time to load the agent into the liposomes,

wherein the external solution and external surfaces of the liposome contain substantially no uncomplexed copper ions; and

wherein the liposomes comprise 0-20 mol % cholesterol; and

wherein said loading is conducted in the absence of ionophore, whereby the therapeutic agent is encapsulated at levels greater than those achieved in the absence of said copper ions.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE 2 APPLICATION NUMBERS PREVIOUSLY RECORDED AT REEL: 07234 FRAME: 0137. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Oct 9, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073133/0142 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF 8 PROPERTY NUMBERS PREVIOUSLY RECORDED AT REEL: 072341 FRAME: 0137. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Oct 8, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073058/0985 →
CHANGE OF NAME Recorded Aug 7, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 072341/0137 →
SECURITY AGREEMENT Recorded May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
RELEASE OF SECURITY INTEREST Recorded May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; CELATOR PHARMACEUTICALS, INC.; CAVION, INC.
Reel/Frame 056150/0708 →
SECURITY AGREEMENT Recorded Jul 12, 2016
From: CELATOR PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 039312/0397 →
RELEASE OF SECURITY INTEREST Recorded Jun 15, 2012
From: THOMAS, MCNERNEY & PARTNERS II, L.P.; TMP NOMINEE II, LLC; TMP ASSOCIATES II, L.P.; DOMAIN PARTNERS VI, L.P.; VENTURES WEST 7 LIMITED PARTNERSHIP; VENTURES WEST 7 U.S. LIMITED PARTNERSHIP; WORKING OPPORTUNITY FUND (EVCC) LTD.; BDC CAPITAL INC.; QUAKER BIOVENTURES, L.P.; GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 028385/0371 →